The oil, standardized to 3% thymoquinone and less than 2% free fatty acids, was found to inhibit opportunistic pathogens associated with acne.
Photo © Shutterstock.com/goodluz
A recent study1 found that a proprietary black seed oil, marketed as B’utyQuin by TriNutra, supported the health of acnes prone skin better than non-standardized black seed oil. The oil, standardized to 3% thymoquinone and less than 2% free fatty acids, was found to inhibit opportunistic pathogens associated with acne, particularly Propionibacterium acnes, demonstrating the product’s ability to significantly impact the microbial growth of microorganism. By contrast, the non-standardized black seed oil was associated by an increase in Propionibacterium acnes. According to TriNutra, the standardized composition of its black seed oil effected sebum/fat production which is a primary food source of microorganisms associated with acne prone and oil skin.
“We are thrilled with the strong results demonstrating that B’utyQuin is a superior product with effective skin healing properties and potent antimicrobial effects,” said Liki von Oppen-Bezalel, PhD, business development director at TriNutra, in a press release. “This study lends additional support to earlier analysis of B’utyQuin and its positive skin health properties as a topical and oral supplement.”
Previously, B’utyQuin was found to demonstrate significant anti-microbial activity in vitro, and was able to relieve irritated, itchy, scaly skin and scalp, as well as seborrheic dermatitis.
Reference
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.
FDA and FTC issue more warning letters to copycat delta-8 THC food products
July 16th 2024The U.S. Food and Drug Administration and Federal Trade Commission have jointly issued warning letters to five companies for selling copycat food products containing delta-8 THC in violation of the Federal Food Drug and Cosmetic Act.